RSU, ISO & Deferred Comp Strategy

Executive Compensation Advisor in Philadelphia

Equity compensation is one of the highest-stakes, lowest-understood pieces of an executive’s financial picture. The wrong RSU sale strategy, a poorly-timed ISO exercise, or an unmanaged deferred-comp election can quietly cost six or seven figures over a career. PIP Wealth provides specialized executive compensation planning for executives at Philadelphia-area employers — on a fee-only, fiduciary basis with no product sales to muddy the advice.

The four pieces of executive comp most plans get wrong

Most executives are advised by generalists who know "you should diversify out of your company stock" but can’t actually walk the math. Here’s what specialized executive comp planning has to address:

1. Restricted Stock Units (RSUs)

RSUs are taxed as ordinary income on vest, regardless of whether you sell or hold. The default behavior of most executives — "I’ll just hold and let it grow" — means you’re effectively buying your company stock at top tax rates with after-tax dollars. Disciplined sell-on-vest strategies almost always beat hold-by-default.

2. Incentive Stock Options (ISOs)

ISOs offer a special tax break (long-term capital gains on sale) but trigger Alternative Minimum Tax (AMT) on exercise if you don’t sell same-day. The interplay between AMT, regular tax, and capital gains rates makes ISO planning genuinely complex — and most generalist advisors get it wrong.

3. Non-Qualified Stock Options (NQSOs)

NQSOs are simpler tax-wise (ordinary income on exercise) but have their own timing trade-offs — especially around 10b5-1 plans, blackout windows, and concentration management.

4. Non-Qualified Deferred Compensation (NQDC)

Deferred comp is one of the highest-leverage planning tools available to senior executives, but the elections are typically made years in advance, are largely irrevocable, and depend on the financial health of the employer. We model these alongside the rest of the financial picture.

How we work with Philadelphia-area executives

Our executive clients work at the major employer ecosystems across the Philadelphia metro:

  • Comcast / NBCUniversal headquarters — complex RSU schedules, performance shares, and deferred comp.
  • Vanguard — partnership-style profit sharing alongside traditional comp.
  • Independence Blue Cross, Penn Medicine, Jefferson Health, Children’s Hospital of Philadelphia — healthcare leadership with 457(b)/457(f) deferred comp and supplemental retirement plans.
  • Lincoln Financial, Aramark, FMC and other Philadelphia-headquartered Fortune 500s — standard equity-comp packages with company-specific election windows.
  • Pharma and life sciences at GSK, Merck Upper Gwynedd, Spark, Adaptimmune, Iovance — biotech-heavy equity packages with high concentration risk.

Each employer’s plan documents are different, the vesting schedules are different, and the planning windows are different. We learn yours.

RSU Vesting Strategy

Disciplined sell-on-vest plans, 10b5-1 trading plans, and tax-aware diversification away from concentration.

ISO & AMT Planning

Modeling the interplay of AMT, regular tax, and long-term capital gains to time exercises optimally.

NQSO Exercise Strategy

Timing exercises against blackout windows, 10b5-1 plans, and tax-bracket targets.

Deferred Compensation

Coordinating annual elections with overall income, retirement timeline, and employer credit risk.

Concentrated Position Management

Reducing single-stock risk over time without unnecessary tax friction or violating insider rules.

Tax-Bracket Coordination

Multi-year planning across the rest of your financial picture — charitable strategies, Roth conversions, retirement contributions.

Who we work with

Our executive comp clients in the Philadelphia area typically include:

  • Mid-career executives at major Philadelphia employers with $1M+ in vested and unvested equity comp.
  • Senior executives and C-suite with significant deferred-comp elections, supplemental retirement plans, and complex equity grants.
  • Tech and biotech professionals with concentrated equity from a recent IPO or acquisition.
  • Pre-retirement executives 2–5 years from leaving, planning the run-out of unvested grants and deferred comp distributions.

The introductory call is free and confidential — we’ll review your equity package and tell you whether we’re the right fit before any formal engagement.

Talk to an advisor who actually understands your equity comp

A 30-minute confidential conversation. Bring your last grant agreement and your most recent paystub — we’ll do the rest.

Schedule a Free Introductory Call